JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $200,350 | +516.2% | 108,297 | +269.7% | 0.00% | – |
Q4 2022 | $32,514 | -66.5% | 29,292 | -29.2% | 0.00% | – |
Q3 2022 | $97,000 | -52.9% | 41,367 | -39.2% | 0.00% | – |
Q2 2022 | $206,000 | -61.8% | 68,055 | -14.3% | 0.00% | – |
Q1 2022 | $539,000 | -18.8% | 79,400 | -0.3% | 0.00% | – |
Q4 2021 | $664,000 | +42.8% | 79,600 | +27.2% | 0.00% | – |
Q3 2021 | $465,000 | -52.0% | 62,600 | -56.1% | 0.00% | – |
Q2 2021 | $969,000 | -14.3% | 142,508 | +29.4% | 0.00% | – |
Q1 2021 | $1,131,000 | -26.6% | 110,122 | -50.0% | 0.00% | – |
Q4 2020 | $1,540,000 | -10.9% | 220,056 | +3.9% | 0.00% | – |
Q3 2020 | $1,729,000 | +805.2% | 211,817 | +664.7% | 0.00% | – |
Q2 2020 | $191,000 | -38.2% | 27,700 | -57.5% | 0.00% | – |
Q1 2020 | $309,000 | -63.9% | 65,100 | -33.7% | 0.00% | – |
Q4 2019 | $857,000 | +732.0% | 98,125 | +216.1% | 0.00% | – |
Q3 2019 | $103,000 | -86.0% | 31,041 | -79.1% | 0.00% | – |
Q2 2019 | $735,000 | +165.3% | 148,558 | +232.9% | 0.00% | – |
Q1 2019 | $277,000 | +218.4% | 44,623 | +73.6% | 0.00% | – |
Q4 2018 | $87,000 | -94.4% | 25,708 | -89.3% | 0.00% | – |
Q3 2018 | $1,562,000 | +8.2% | 240,282 | +27.4% | 0.00% | – |
Q2 2018 | $1,444,000 | -82.3% | 188,612 | -48.4% | 0.00% | -100.0% |
Q1 2018 | $8,170,000 | +2346.1% | 365,550 | +1294.2% | 0.00% | – |
Q4 2017 | $334,000 | – | 26,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |